Ireland
--:--IST
Latest
PulseAI of Belfast Says FDA Cleared Its Wearable ECG AI Airmid Éireann 1.6 Adds India and China Trials, Swiss Prices Irish Cancer Trial Enrolment at 2.9%, Under Half 6% Target FDA Accelerated Approval for J&J's Head and Neck Cancer Drug Korea Misses 2026 Biosimilar Approvals, Bets on Keytruda ArrayPatch Closes €3.2m Seed for GLP-1 Microneedle Patch PulseAI of Belfast Says FDA Cleared Its Wearable ECG AI Airmid Éireann 1.6 Adds India and China Trials, Swiss Prices Irish Cancer Trial Enrolment at 2.9%, Under Half 6% Target FDA Accelerated Approval for J&J's Head and Neck Cancer Drug Korea Misses 2026 Biosimilar Approvals, Bets on Keytruda ArrayPatch Closes €3.2m Seed for GLP-1 Microneedle Patch
Clinical Trials in China / NCT03324698
Active, not recruiting Observational

The Natural History of Chronic Pancreatitis

NCT03324698 · tracked via the Priya Life Science China tracker
Sponsor
Changhai Hospital
Phase
Observational
Started
2000-01-01
Last updated
2026-09-23

Condition(s) studied

Chronic PancreatitisComplicationRisk Factors

Study summary

Chronic pancreatitis (CP) is a disease characterized by inflammation and their replacement by fibrotic tissue. The destruction of pancreatic function and structure are the main complications. This retrospective-prospective, multicenter, cohort study was conducted. This study aimed to observe the natural history of CP in China, analyse the risk factors for CP complications, and establish individual predictions.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients diagnosed with chronic pancreatitis according to Asia-Pacific consensus Exclusion Criteria: * Pancreatic cancer diagnosed within 2 years after the diagnosis of chronic pancreatitis * Groove pancreatitis * Autoimmune pancreatitis

Primary outcome measure(s)

  • Pancreatic cancer — Dec 31, 2017
    Pancreatic cancer developed in chronic pancreatitis patients
  • Diabetes mellitus — Dec 31, 2017
    Endocrine insufficiency developed in chronic pancreatitis patients
  • Steatorrhea — Dec 31, 2017
    Exocrine insufficiency developed in chronic pancreatitis patients
  • Pancreatic pseudocyst — Dec 31, 2017
    Pancreatic pseudocyst developed in chronic pancreatitis patients
  • Common bile duct stricture — Dec 31, 2017
    Common bile duct stricture developed in chronic pancreatitis patients

Trial sites (1)

FacilityCityRegionStatus
Changhai Hospital, Second Military Medical University Shanghai China

More Changhai Hospital trials in China

CAR-NK Cells (CL-NK-003) in Pancreatic Cancer Recruiting
Direct Visualization ERAT Versus Laparoscopic Appendectomy in Adults With Acute Uncomplicated Appendicitis Recruiting
Pre-Packaged Low-Residue Diet Assisting Bowel Preparation in Patients With Inflammatory Bowel Disease Recruiting
Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC) Recruiting
Metformin in Post Chronic Pancreatitis Diabetes Mellitus Recruiting

Other trials for the same condition

Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site Recruiting
Metformin in Post Chronic Pancreatitis Diabetes Mellitus Recruiting
Pinaverium Bromide Preventing Post Extracorporeal Shock Wave Lithotripsy Pancreatitis and Painful (PBPEP) Enrolling by invitation
Single Plastic Stent Vs. Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancreatitis Recruiting
Real World Study of End-stage Liver Disease in China Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03324698 on ClinicalTrials.gov ↗ ← All trials in China